Literature DB >> 11298903

Paradigmatic shifts in occlusion and temporomandibular disorders.

M M Ash1.   

Abstract

There are several terms that identify proposed paradigms for the way things ought to be carried out in the health sciences: evidence-based, cause-and-effect, diagnostic gold-standard, patient-centred-outcomes, risk assessment, cost/benefit/risk, and efficacious/effective. Collectively these paradigms exhibit varying degrees of interdependence, and have the potential for changing the way dentistry is practiced. A paradigm can be thought of as a standard by which research and health science ought to be conducted and evaluated. In this sense scientists and clinicians try to figure out how to account for various observations and phenomena dictated by paradigms or models of health care; however, it may become necessary to shift to new paradigms that are more consistent with scientific and clinically reality. Some of the potential effects of these shifting paradigms on the practice and teaching of occlusion and temporomandibular disorders are considered.

Entities:  

Mesh:

Year:  2001        PMID: 11298903     DOI: 10.1046/j.1365-2842.2001.00658.x

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN: 0305-182X            Impact factor:   3.837


  4 in total

1.  Occlusal interferences: how can this concept influence the clinical practice?

Authors:  Adriano Fonseca Lima; Andrea Nóbrega Cavalcanti; Luis Roberto Marcondes Martins; Giselle Maria Marchi
Journal:  Eur J Dent       Date:  2010-10

Review 2.  Occlusion, TMDs, and dental education.

Authors:  Major M Ash
Journal:  Head Face Med       Date:  2007-01-03       Impact factor: 2.151

3.  Prevalence of temporomandibular disorders and its association with malocclusion in children: A transversal study.

Authors:  Monica Macrì; Giovanna Murmura; Antonio Scarano; Felice Festa
Journal:  Front Public Health       Date:  2022-09-09

Review 4.  Temporomandibular Disorders: "Occlusion" Matters!

Authors:  Robert J A M de Kanter; Pasquale G F C M Battistuzzi; Gert-Jan Truin
Journal:  Pain Res Manag       Date:  2018-05-15       Impact factor: 3.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.